Review

Panic disorders: The role of genetics and epigenetics

  • Received: 08 January 2018 Accepted: 02 July 2018 Published: 27 July 2018
  • Panic disorder is characterized by symptoms with abrupt surges of fear with palpitations, sweating, trembling, heat sensations. Considering its disease burden on each individual and on society, understanding its etiology is important. Though no one specific etiology has been known, like other psychiatric disorders, multiple factors such as genetic, environmental, neurobiological, psychopathological factors have been suggested. In this article, we reviewed currently known etiologies and related study results, regarding especially genetic and epigenetic aspects of the panic disorder. Early studies, including twin studies, family studies, adoption studies suggested highly familial trait of panic disorder. Linkage studies, either, found panic disorder is not a single gene disorder but confirmed existence of multiple related genes. Chromosome and candidate gene studies found few related genes, NPY, ADORA2A, COMT, IKBKE. Newer method, genome-wide association studies (GWAS) have been searching for newer genes. No genome-wide significant genes, however, were detected, confirming previously known candidate genes, NPY5R on 4q31.3-32, BDKRB2 on 14q32, instead. Epigenetic modification has also been studied on many different psychiatric disorders. Monoamine oxidase A (MAOA) hypomethylation, taken together with negative life events, showed relation with panic disorder. Glutamate decarbodylases 1 (GAD1) hypomethylation was also specific on panic disorder patients. Relation with noradrenaline transporter (NET) gene SLC6a2 promoter methylation has also been studied. In conclusion, no specific gene or epigenetic pattern can fully explain etiology of panic disorder. Few genes and epigenetic patterns, however, showed strong association with panic disorder compared to healthy controls. Considering its multivariable background, further studies with larger populations can confirm current results and clarify etiologies of panic disorder.

    Citation: Eun Jeong Kim, Yong-Ku Kim. Panic disorders: The role of genetics and epigenetics[J]. AIMS Genetics, 2018, 5(3): 177-190. doi: 10.3934/genet.2018.3.177

    Related Papers:

    [1] Changhong Guo, Shaomei Fang, Yong He, Yong Zhang . Some empirical studies for the applications of fractional $ G $-Brownian motion in finance. Quantitative Finance and Economics, 2025, 9(1): 1-39. doi: 10.3934/QFE.2025001
    [2] Lichao Tao, Yuefu Lai, Yanting Ji, Xiangxing Tao . Asian option pricing under sub-fractional vasicek model. Quantitative Finance and Economics, 2023, 7(3): 403-419. doi: 10.3934/QFE.2023020
    [3] Salvatore Scognamiglio . Longevity risk analysis: applications to the Italian regional data. Quantitative Finance and Economics, 2022, 6(1): 138-157. doi: 10.3934/QFE.2022006
    [4] Fabrizio Di Sciorio, Raffaele Mattera, Juan Evangelista Trinidad Segovia . Measuring conditional correlation between financial markets' inefficiency. Quantitative Finance and Economics, 2023, 7(3): 491-507. doi: 10.3934/QFE.2023025
    [5] Salvador Cruz Rambaud, Piedad Ortiz Fernández, Javier Sánchez García, Paula Ortega Perals . A proposal of concentration measures for discount functions. Quantitative Finance and Economics, 2024, 8(2): 347-363. doi: 10.3934/QFE.2024013
    [6] Salvador Cruz Rambaud, Jorge Hernandez-Perez . A naive justification of hyperbolic discounting from mental algebraic operations and functional analysis. Quantitative Finance and Economics, 2023, 7(3): 463-474. doi: 10.3934/QFE.2023023
    [7] Etti G. Baranoff, Patrick Brockett, Thomas W. Sager, Bo Shi . Was the U.S. life insurance industry in danger of systemic risk by using derivative hedging prior to the 2008 financial crisis?. Quantitative Finance and Economics, 2019, 3(1): 145-164. doi: 10.3934/QFE.2019.1.145
    [8] Jin Liang, Hong-Ming Yin, Xinfu Chen, Yuan Wu . On a Corporate Bond Pricing Model with Credit Rating Migration Risksand Stochastic Interest Rate. Quantitative Finance and Economics, 2017, 1(3): 300-319. doi: 10.3934/QFE.2017.3.300
    [9] Alexander D. Smirnov . Sigmoidal dynamics of macro-financial leverage. Quantitative Finance and Economics, 2023, 7(1): 147-164. doi: 10.3934/QFE.2023008
    [10] Longfei Wei, Lu Liu, Jialong Hou . Pricing hybrid-triggered catastrophe bonds based on copula-EVT model. Quantitative Finance and Economics, 2022, 6(2): 223-243. doi: 10.3934/QFE.2022010
  • Panic disorder is characterized by symptoms with abrupt surges of fear with palpitations, sweating, trembling, heat sensations. Considering its disease burden on each individual and on society, understanding its etiology is important. Though no one specific etiology has been known, like other psychiatric disorders, multiple factors such as genetic, environmental, neurobiological, psychopathological factors have been suggested. In this article, we reviewed currently known etiologies and related study results, regarding especially genetic and epigenetic aspects of the panic disorder. Early studies, including twin studies, family studies, adoption studies suggested highly familial trait of panic disorder. Linkage studies, either, found panic disorder is not a single gene disorder but confirmed existence of multiple related genes. Chromosome and candidate gene studies found few related genes, NPY, ADORA2A, COMT, IKBKE. Newer method, genome-wide association studies (GWAS) have been searching for newer genes. No genome-wide significant genes, however, were detected, confirming previously known candidate genes, NPY5R on 4q31.3-32, BDKRB2 on 14q32, instead. Epigenetic modification has also been studied on many different psychiatric disorders. Monoamine oxidase A (MAOA) hypomethylation, taken together with negative life events, showed relation with panic disorder. Glutamate decarbodylases 1 (GAD1) hypomethylation was also specific on panic disorder patients. Relation with noradrenaline transporter (NET) gene SLC6a2 promoter methylation has also been studied. In conclusion, no specific gene or epigenetic pattern can fully explain etiology of panic disorder. Few genes and epigenetic patterns, however, showed strong association with panic disorder compared to healthy controls. Considering its multivariable background, further studies with larger populations can confirm current results and clarify etiologies of panic disorder.


    The randomness of interest rates deeply influences the accuracy of actuarial values of life insurances and life annuities, especially for long-term policies. Hence it is important to consider stochastic interest models in actuarial science. So far, there are numerous papers which have investigated stochastic interest models and their applications in actuarial science. Bellhouse and Panjer Bellhouse and Panjer(1980, 1981) computed the moments of insurance and annuity functions based on AR(1) stochastic interest models. Li et al. (2017) also used AR(1) interest models in the survivorship life insurance portfolios. Dhaene (1989) modeled the force of interest as an ARIMA(p, d, q) process in the analysis of the moments of present value functions. Cai and Dickson (2004) used a Markov process to model the interest rates in the research of ruin probability. Beekman and Fuelling(1990, 1991) modeled the accumulated force of interest as an Ornstein-Uhlenbeck process and a Wiener process respectively in the study of continuous-time life annuity. Later, Hoedemakrs et al. (2005) and Dufresne (2007) discussed the distribution of life annuity under Beekman and Fuelling's methods. Zhao et al. (2007) and Zhao and Zhang (2012) expressed the accumulated force of interest by a Wiener Process and a Poisson Process in the research of optimal dividend and pricing perpetual options respectively.

    Generally, stochastic interest models based on time series methods require the assumption that the interest rate in one year is fixed, which does not always fit in with market interest rates. The methods by modeling the accumulated force of interest bring convenience to both theoretical analysis and calculation, but the behavior of the force of interest can't be indicated distinctly. So Parker(1994a, 1994b) studied the first three moments of homogeneous portfolios of life insurance and endowment policies by modeling the force of interest directly based on a Wiener process or an Ornstein-Uhlenbeck process. Especially, the modeling method based on Ornstein-Uhlenbeck process is also called as Vasicek model in finance, and has been applied extensively (such as Boulier et al., 2001; Liang et al., 2017, etc.). Parker (1994c) further compared the randomness of annuity of the models describing the accumulated force of interest with that of the ones describing the force of interest directly. Considering stochastic jumps of the force of interest in financial markets, Li et al. (2017) modeled the force of interest directly by a compound Poisson process.

    Considering the change of yield rate in insurance company, the following two aspects are involved: stochastic continuous fluctuation from risk-free investments of insurance companies and stochastic jumps from adjustments of market interest rate (epically official rate of interest). So we might combine these two parts together to aim to introduce a class of interest models, in which the force of interest is expressed by a compound Poisson process and a Brownian motion. Our model is a generalization of Parker(1994a, 1994b, 1994c) and Li et al. (2017). It not only considers discrete and continuous changes simultaneously, but also assumes random adjustment range in each jump about the force of interest. These characters can interpret random changes of interest on financial market. In literature, stochastic interest models with jumps have been studied by stochastic differential equation, for example, Brigo and Mercurio (2006), Deng (2015), Li et al. (2016) and Hu and Chen (2016) etc. But the modeling thinking-way and research method are different from the one presented in this paper.

    The paper is organized as follows. In Section 2, we introduce the stochastic interest model driven by a compound Poisson process and a Brownian motion. In Section 3, we give an explicit formula of the expected discounted functions of the proposed model under general circumstances, discuss the validity of this model and investigate their properties under different parameter and distribution settings through analytical and numerical analysis. In Section 4, we give actuarial present values of life annuities in discrete and continuous conditions. Lastly, we end this paper with a conclusion.

    Assume that all random variables and stochastic processes under consideration are defined on an appropriate probability space $(\Omega, P, \mathscr{F})$ and are integrable. In this section, we construct a class of stochastic interest models including a discrete part and a continuous part.

    For the discrete part, we follow and generalize the idea of Li et al. (2017), and the following three assumptions are satisfied:

    (1) The jumping number of the force of interest can be expressed by a Poisson process;

    (2) The adjustment direction (rise or fall) of interest rates in every jump of the force of interest is independent of each other; and

    (3) The adjustment ranges of interest rates in all jumps are independent and identically distributed.

    For the continuous part, Brownian motion is usually used to describe stochastic tiny fluctuations of all kinds of financial assets. Due to the excellent mathematical properties of Brownian motion and the consistency between the change rules of finance assets and stochastic fluctuations of Brownian motion, we choose Brownian motion to describe continuous tiny fluctuations of the force of interest.

    So the force of interest $\delta_t, t\geq 0$ is expressed by

    $ \delta_t = \delta_0+\sum\limits_{i = 0}^{N(t)}Y_i+\sigma B(t), t\in [0, +\infty)\}. $ (1)

    where $\{N(t), t\geq0\}$ is a Poisson process with parameter $\lambda$ and denotes the jumping number of the force of interest on interval $[0, t]$. $\{Y_i\}_{i = 1}^{+\infty}$ are independent and identically distributed random variables and each $Y_i$ expresses the jumping range of the $i$-th jump of the force of interest. So $\sum_{i = 1}^{N(t)}Y_i$, $t>0$, is a compound Poisson process. The stochastic process $\{B(t), t\geq 0\}$ is a standard Brownian motion which describes the stochastic fluctuations of the force of interest and the constant $\sigma$ represents the fluctuation intensity.

    The jumping range of the force of interest $Y_i$ can be further written as

    $Y_i = I_i\cdot Z_i, $

    where $I_i(i = 1, 2, 3, ...)$ is the direction of the $i$-th jump of the force of interest with $\{I_i = 1\}$ for a rise and $\{I_i = -1\}$ for a fall. The random variable $I_i(i = 1, 2, 3, ...)$ obeys $P(I_i = 1) = 1-P(I_i = -1) = p (0\leq p \leq 1)$, in which $p$ is called the up-jumping probability of the force of interest. The random variable $Z_i(i = 1, 2, 3...)$ is non-negative and can be interpreted as the adjustment range of the $i$-th jump of the force of interest with identical distribution $F(z) = P(Z_i\leq z)$. Both of $\{I_i(i = 1, 2, 3, ...)\}$ and $\{Z_i(i = 1, 2, 3, ...)\}$ are independent and identically distributed sequences of random variables. Furthermore, the random sequences $\{I_i(i = 1, 2, 3, ...)\}$, $\{Z_i(i = 1, 2, 3, ...)\}$, $\{N(t), t\geq0\}$ and $\{B(t), t\geq 0\}$ are independent of each other.

    Remark 1. If $P(Z_i = 0) = 1$, or $P(Z_i = \alpha) = 1$ and $\sigma = 0$, our interest model will be reduced to one in Parker (1994c) and Li et al. (2017) respectively.

    Here, we give an important property (refer to Ross (1996)) on Poisson process which will be used in the following analysis.

    Lemma 1. For a Poisson process, if the occur times of all the events are considered as unordered random variables under the condition $N(t) = n$, these random variables are distributed independently and uniformly on the time interval $[0, t]$.

    In this section, we will study the accumulated interest force function and the expected discounted function of the stochastic interest model (1).

    The accumulated interest force on the time interval $[0, t]$ can be expressed as

    $ Jt0=t0δsds=t0(δ0+N(s)i=1Yi+σB(s))ds=δ0t+t0(N(s)i=1Yi)ds+σt0B(s)ds=δ0t+H1(t)+H2(t).
    $
    (2)

    (a) In formula (2), by changing the integral direction (refer to Section 2.2 in Li et al. (2017)), we obtain

    $ H_1 = \sum\limits_{i = 1}^{N(t)}Y_i(t-T_i) = \sum\limits_{i = 1}^{N(t)}I_i\cdot Z_i(t-T_i), $ (3)

    where $T_i~~(i = 1, 2, 3, ...)$ denotes the $i$-th jumping time of the force of interest.

    (b) Through stochastic calculus (see Klebaner (2005)), we know

    $ H_2\sim N(0, \sigma^2t^3/3). $ (4)

    So from formulas (2), (3) and (4), we have

    $ J_0^t = \delta_0\cdot t+\sum\limits_{i = 1}^{N(t)}I_i\cdot Z_i(t-T_i)+H_2. $ (5)

    The discounted function, which is the random present value of one-unit payment at time $t$, can be expressed as

    $ \exp\left(-J_0^t\right) = \exp\left(-\left(\delta_0\cdot t+H_2\left(t\right)\right)\right)\prod\limits_{i = 1}^{N(t)}\exp(-I_i\cdot Z_i(t-T_i)). $ (6)

    From formula (4) and Section 2 in Parker (1994c), we have,

    $ E\left[\exp\left(-\left(\delta_0\cdot t+H_2\left(t\right)\right)\right)\right] = \exp\left(\left(-\delta_0+t^2\sigma^2/6\right)t\right). $ (7)

    Moreover, it can be obtained from the law of total expectation that

    $ E\left[\prod\limits_{i = 1}^{N(t)}\exp(-I_i\cdot Z_i(t-T_i))\right] = E\left[E\left[\prod\limits_{i = 1}^{N(t)}\exp\left(-I_i\cdot Z_i(t-T_i)\right)|N(t)\right]\right]. $ (8)

    By Lemma 1 and the independent assumptions in Section 2, we have

    $      E[N(t)i=1exp(IiZi(tTi))|N(t))]=E[N(t)i=1exp(IiZi(tUi))]=N(t)i=1E[exp(IiZi(tUi))]=N(t)i=1(E[exp(Zi(tUi))]p+E[exp(Zi(tUi))](1p))=N(t)i=1(pt+0t0exp(z(tu))dudF(z)+1pt+0t0exp(z(tu))dudF(z))=βN(t)t,
    $
    (9)

    where the random variables, $U_1, U_2, ..., U_{N(t)}$ are independent and identically distributed on the time interval $[0, t]$ and

    $\beta_t = \frac{1}{t} {\int_0^{+\infty} \frac{1}{z} \left(\left(p(1-\exp(-zt)\right)+(1-p)\left(\exp(zt)-1)\right) \right) {\rm d}F(z)}.$

    Based on the foregoing analysis, we obtain the following theorem.

    Theorem 1. Under the stochastic interest model (1), the expected discounted function can be expressed as

    $ E\left[\exp\left(-J_0^t\right)\right] = \exp\left(\left(-\delta_0+t^2\sigma^2/6+\lambda(\beta_t-1)\right)t\right). $ (10)

    Proof. See the Appendix.

    Remark 2. From equation (10) and $\beta_t$ in formula (9), we can prove that the expected discounted function is an increasing function of $\sigma$ and a decreasing function of $p$. We will further demonstrate this property in Section 3.2 through numerical analysis.

    In practice, the jump sizes of interest rate are relatively fixed, for examples, the Federal reserve rate and the Chinas central bank benchmark interest rate etc. In addition, the jump sizes of interest rate are not too big. Hence, we give three special distributions about the jump size as special cases in the following corollary.

    Corollary 1. The expected discounted function $E[\exp(-J_0^t)]$ is influenced by the distribution function $F(z)$ and the up-jumping probability $p$. There are some special cases of $F(z)$ and $p$ as follows,

    (1) If $P(Z_i = \alpha) = 1~(i = 1, 2, 3, ...)$ for a positive constant $\alpha$, the result of $\beta_t$ is consistent with that in Li et al. (2017) which is generalized further in this paper, we obtain that

    $\beta_t = \frac{1}{\alpha t}\left(p\left(1-\exp(-\alpha t)\right)+(1-p)\left(\exp(\alpha t)-1\right)\right).$

    (2) If $P(Z_i = \alpha_1) = q = 1-P(Z_i = \alpha_2)~~(i = 1, 2, 3, ...)$ for two positive constants $\alpha_1$ and $\alpha_2$, that is, $Z_i(i = 1, 2, 3, ...)$ obeys a two-point distribution, we have that

    $\beta_t = \frac{q\left(1-\exp(-\alpha_1t)\right)}{\alpha_1t}\left(p+(1-p)\exp(\alpha_1t)\right)+\frac{(1-q)(1-\exp(-\alpha_2t))}{\alpha_2t}(p+(1-p)\exp\left(\alpha_2t)\right).$

    (3) If $F(z) = z/\theta$ for $z\in [0, \theta]$, that is, the random variable $Z_i(i = 1, 2, 3, ...)$ is uniformly distributed on the time interval $[0, \theta]$, we have that

    $\beta_t = \frac{1}{\theta t} \left({p\int_0^{\theta}\frac{1}{z}\left(1-\exp(-zt)\right)dz+(1-p)\int_0^{\theta}\frac{1}{z}\left(\exp(zt)-1 \right)dz}\right).$

    (4) If $p = 0$, the market interest will always jump down at the moments when interest rates jump. Because $\exp(zt)-1>zt$, we have that

    $\beta_t = \int_0^{\infty}\frac{1}{zt}\left(\exp(zt)-1\right){\rm d}F(z) \gt \int_0^{\infty}{\rm d}F(z) = 1.$

    In this case, the interest rate might be negative if the jumping number of the interest rates on the time interval $[0, t]$ is sufficiently large.

    (5) If $p = 1$, the market interest will always jump up at the moments when the interest rates jump. Because $1-\exp(-zt) < zt$, we have that

    $\beta_t = \int_0^{\infty}\frac{1}{zt}\left(1-\exp(-zt)\right){\rm d}F(z) \lt \int_0^{\infty}{\rm d}F(z) = 1.$

    In this case, the larger the jumping number of interest rates is, the smaller the expected discounted function is.

    As a general rule, the accumulated interest force function should be increasing with respect to time $t$ which means that the expected discounted function in formula (10) is decreasing. This property is called the validity of stochastic interest model which will be analyzed in this section. Now, we will discuss how to restrict the value of the future time $t$ in order to ensure this validity.

    Let $f(t) = (\delta_0+\lambda)t-\sigma^2t^3/6+\lambda\beta_tt$, and we should ensure this function is increasing. Obviously, the derivative function of $f(t)$ exists if the function $f(t)$ is finite. In fact, we can find that $\lim_{t\rightarrow 0^+}\beta_t = 1$ and $\beta_t\leq \int_0^{+\infty}\frac{\exp{zt}-1}{zt}dF(z)~~t\in(0, +\infty).$ Hence, if $F(\cdot)$ is a light-tailed distribution, $\beta_t$ is finite for any $t\in [0, +\infty)$, and so is the function $f(t)$.

    Under the condition of light-tailed distribution, the derivative function can be expressed as

    $f'(t) = (\delta_0+\lambda)-\sigma^2t^2/2-\lambda\int_0^{\infty}\left(pe^{-zt}+(1-p)e^{zt}\right)dF(z).$

    We can find that $f'(0) = \lambda_0>0$ and $\lim_{t\rightarrow +\infty}f'(t) < 0$, then there is at least one critical value in interval $(0, +\infty)$ which satisfies $f'(t) = 0$ and the first one is denoted as $t^{\ast}$. Hence, this model is valid if time $t\in[0, t^{\ast}]$. Now, we will try to find the values of $t^{\ast}$ under various cases of the probability distribution of $Z_i$, $F(\cdot)$ given in Corollary 1 respectively.

    (1) In case that $P(Z_i = \alpha) = 1~(i = 1, 2, 3, ...)$ for a positive constant $\alpha$, we have

    $f'(t) = (\delta_0+\lambda)-\sigma^2t^2/2-\lambda\left(pe^{-\alpha t}+(1-p)e^{\alpha t}\right).$

    (2) In case that $P(Z_i = \alpha_1) = q = 1-P(Z_i = \alpha_2)~~(i = 1, 2, 3, ...)$ for two positive constants $\alpha_1$ and $\alpha_2$, we have

    $f'(t) = (\delta_0+\lambda)-\sigma^2t^2/2-\lambda\left[q\left(pe^{-\alpha_1 t}+(1-p)e^{\alpha_1 t}\right)+(1-q)\left(pe^{-\alpha_2 t}+(1-p)e^{\alpha_2 t}\right)\right].$

    (3) In case that $F(z) = z/\theta$ for $z\in [0, \theta]$, we have that

    $f'(t) = (\delta_0+\lambda)-\sigma^2t^2/2-\frac{\lambda}{\theta t}\left[p\left(1-e^{-\theta t}\right)+(1-p)\left(e^{\theta t}-1\right)\right].$

    For each case above, since there are exponential functions part and power function part in equation $f'(t) = 0$, it is very difficult to solve this equation directly. However, we can obtain the value of $t^{\ast}$ by numerical approach and then can use the interest model in formula (1) when $t\in(0, t^{\ast})$. For instance, if $\delta_0 = 0.04, \lambda = 2, \sigma = 0.01, \alpha = 0.0025$ and $p = 0.6$ under case (1), we can obtain $t^{\ast} = 37.01$; and if $\delta_0 = 0.04, \lambda = 2, \sigma = 0.01, \theta = 0.004$ and $p = 0.6$ under case (3), we can obtain $t^{\ast} = 35.08$.

    In this subsection, we analyze the changes of the expected discounted function under different assumptions in Corollary 1. We consider three types of distribution function $F(z)$, including one-point distributions, two-point distributions and uniform distributions. The parameter $\delta_0$ is assumed to be $0.04$. Firstly, we suppose $\lambda = 2$ and $t = 10$ to calculate the values of the expected discounted functions, shown in Tables 13. In addition, the range of the parameters of $F(z)$ is chosen based on the condition of jump amplitudes of major market interest rates (such as the Federal reserve rate and the China's central bank benchmark interest rate).

    Table 1.  Values of expected discounted functions when $F(z)$ is an one-point distribution.
    $\alpha$ Values of expected discounted functions
    $p=0.4$ $p=0.4$ $p=0.5$ $p=0.5$ $p=0.6$ $p=0.6$ $p=0.7$ $p=0.7$
    $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$
    0.0030 0.7259 0.7631 0.6836 0.7187 0.6438 0.6768 0.6063 0.6374
    0.0028 0.7227 0.7598 0.6834 0.7184 0.6462 0.6793 0.6110 0.6423
    0.0026 0.7196 0.7565 0.6831 0.7181 0.6485 0.6818 0.6156 0.6472
    0.0024 0.7165 0.7532 0.6829 0.7179 0.6509 0.6843 0.6204 0.6522
    0.0022 0.7134 0.7500 0.6827 0.7177 0.6533 0.6868 0.6252 0.6572
    0.0020 0.7103 0.7468 0.6825 0.7175 0.6557 0.6894 0.6300 0.6623

     | Show Table
    DownLoad: CSV
    Table 2.  Values of expected discounted functions when $F(z)$ is a two-point distribution.
    $\alpha_1$ $\alpha_2$ $q$ Values of expected discounted functions
    $p=0.4$ $p=0.5$ $p=0.5$ $p=0.6$ $p=0.6$ $p=0.7$
    $\sigma=0.01$ $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.02$
    0.001 0.003 0.40 0.7136 0.6829 0.7179 0.6535 0.6870 0.6157
    0.001 0.003 0.50 0.7106 0.6827 0.7177 0.6560 0.6896 0.6625
    0.001 0.003 0.60 0.7076 0.6825 0.7175 0.6584 0.6922 0.6677
    0.001 0.004 0.40 0.7233 0.6839 0.7189 0.6466 0.6798 0.6427
    0.001 0.004 0.50 0.7186 0.6835 0.7186 0.6502 0.6835 0.6502
    0.001 0.004 0.60 0.7139 0.6832 0.7182 0.6538 0.6873 0.6577
    0.002 0.003 0.40 0.7196 0.6832 0.7182 0.6486 0.6818 0.6473
    0.002 0.003 0.50 0.7181 0.6831 0.7181 0.6497 0.6831 0.6497
    0.002 0.003 0.60 0.7165 0.6830 0.7180 0.6509 0.6843 0.6522
    0.002 0.004 0.40 0.7294 0.6841 0.7192 0.6417 0.6746 0.6328
    0.002 0.004 0.50 0.7262 0.6839 0.7189 0.6440 0.6771 0.6376
    0.002 0.004 0.60 0.7230 0.6836 0.7186 0.6464 0.6795 0.6425

     | Show Table
    DownLoad: CSV
    Table 3.  Values of expected discounted functions when $F(z)$ is an uniform distribution.
    $\theta$ Values of expected discounted functions
    $p=0.4$ $p=0.4$ $p=0.5$ $p=0.5$ $p=0.6$ $p=0.6$ $p=0.7$ $p=0.7$
    $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$
    0.0040 0.7107 0.7471 0.6828 0.7178 0.6560 0.6897 0.6303 0.6626
    0.0035 0.7068 0.7431 0.6825 0.7175 0.6590 0.6928 0.6364 0.6690
    0.0030 0.7030 0.7391 0.6823 0.7172 0.6621 0.6960 0.6425 0.6755
    0.0025 0.6993 0.7352 0.6821 0.7170 0.6652 0.6993 0.6488 0.6821
    0.0020 0.6957 0.7313 0.6819 0.7168 0.6684 0.7027 0.6552 0.6887

     | Show Table
    DownLoad: CSV

    It can be observed from Table 1, Table 2 and Table 3 that the values of the expected discounted functions become larger with increasing $\sigma$ or decreasing $p$ under three distribution assumptions. This result verifies Remark 2. Furthermore, we can obtain that the values of the expected discounted functions become larger with increasing $\alpha$ under the assumption $P(Z_i = \alpha) = 1$, or with increasing $q$, decreasing both $\alpha_1$ and $\alpha_2$ under the two-point distribution assumption for $Z_i$, or with decreasing $\theta$ under the uniform distribution assumption for $Z_i$ if $p\leq0.5$. The values change in the opposite direction if $p\geq0.6$.

    Remark 3. In the above tables, we only display partial results due to limited space. We also find that there is an equilibrium up-jumping probability $p^{\ast}$ under any one of these three assumptions when the time $t = 10$, which satisfies $0.5 < p^{\ast} < 0.6$. The change regulation for $p < p^{\ast}$ and $p>p^{\ast}$ is similar to that when $p = 0.5$ and $p = 0.6$ respectively. In fact, $p^{\ast}$ is the solution of equation $\beta_t = 1$ which is related to $F(z)$ and $t$. So it can be expressed as $p^{\ast}(F(z), t)$.

    In Figures 16, we present the expected discounted functions as functions of time under different settings. In Figure 1, the upper five curves show the expected discounted functions for $\alpha = 0.0028$, $0.0026$, $0.0024$, $0.0022$ and $0.0020$ from top to bottom under the one-point distribution assumption when $p = 0.5$, while the lower five curves show those functions from bottom to top when $p = 0.6$; in Figure 3, the upper five curves show the expected discounted functions for $q = 0.40$, $0.45$, $0.50$, $0.55$ and $0.60$ from top to bottom under the two-point distribution assumption when $p = 0.5$, while the lower five curves show those functions from bottom to top when $p = 0.6$; in Figure 5, the upper five curves show the expected discounted functions for $\theta = 0.0040, 0.0035, $ $0.0030, 0.0025$ and $0.0020$ from top to bottom under the uniform distribution assumption when $p = 0.5$, while the lower five curves show those functions from bottom to top when $p = 0.6$; and in Figure 2, Figure 4 and Figure 6, every upper five curves show the expected discounted functions from bottom to top for $\lambda = 0.5$, $1$, $1.5$, $2$ and $2.5$ with other parameters keep constant respectively when $p = 0.5$ under three distribution assumptions respectively and the lower five curves show the corresponding expected discounted functions from bottom to top respectively when $p = 0.6$.

    Figure 1.  Curves of expected discounted functions for different $p$ and $\alpha$ when $F(z)$ is an one-point distribution.
    Figure 2.  Curves of expected discounted functions for different $p$ and $\lambda$ when $F(z)$ is an one-point distribution.
    Figure 3.  Curves of expected discounted functions for different $p$ and $q$ when $F(z)$ is a two-point distribution.
    Figure 4.  Curves of expected discounted functions for different $p$ and $\lambda$ when $F(z)$ is a two-point distribution.
    Figure 5.  Curves of expected discounted functions for different $p$ and $\theta$ when $F(z)$ is an uniform distribution.
    Figure 6.  Curves of expected discounted functions for different $p$ and $\lambda$ when $F(z)$ is an uniform distribution.

    From Figures 16, we further observe that the differences between the values of expected discounted functions under different settings become significantly large as the parameter $p$ or the time $t$ increases. This implies that the expected discounted functions is sensitive to $F(z)$ and $\lambda$ for large $p$ and $t$. Hence, more emphasis is required on the selection of parameters in the up-cycle of interest rate.

    In this section, we will apply the proposed stochastic interest model (1) to discrete life annuity and continuous life annuity, life insurance payable at the end of the year of death and life insurance payable at the moment of death. The actuarial present values (APVs) for these life annuities and life insuriance will be shown under different stochastic interest assumptions.

    Following Bowers et al. (1997), the symbol $(x)$ denotes a life-age-$x$. The future lifetime and the curate-future-lifetime of $(x)$ are indicated by $T(x)$ and $K(x)$ respectively.

    In insurance science, there are two types of discrete life annuities which are discrete life annuity-due and discrete life annuity-immediate. Without loss of generality, we only consider the former. In the nomenclature, an $n$-year temporary life annuity-due of one per year is the one that pays one unit amount at the beginning of each year while the annuitant $(x)$ survives during the next $n$ years and the actuarial present value of this life annuity is denoted by $\ddot{a}_{x:\overline{n|}}$.

    Referring to Chapter 5 in Bowers et al. (1997), the actuarial present value of this life annuity $\ddot{a}_{x:\overline{n|}}$ can be expressed as

    $ \ddot{a}_{x:\overline{n|}} = E\left[ \sum\limits_{k = 0}^{n-1}\exp\left(-\int_0^k\delta_tdt\right){}P(K(x)\geq k) \right] = \sum\limits_{k = 0}^{n-1}E\left[ \exp\left(-\int_0^k\delta_tdt \right)\right]{}_kp_x, $ (11)

    where $_kp_x$ is the probability that the annuitant $(x)$ will attain age $x+k$. Combining (11) with (10), we obtain

    $ \ddot{a}_{x:\overline{n|}} = \sum\limits_{k = 0}^{n-1}\exp\left(\left(-\delta_0+k^2\sigma^2/6+\lambda(\beta_k-1)\right)k \right){}_kp_x. $ (12)

    Next, we consider the $n$-year temporary continuous life annuity for the annuitant $(x)$, and the corresponding actuarial present value is denoted by $\overline{a}_{x:\overline{n|}}$. From Chapter 5 in Bowers et al. (1997), we have that

    $\overline{a}_{x:\overline{n|}} = \int_0^n\overline{a}_{\overline{t|}}{\rm d}F_{T(x)}(t)+\overline{a}_{\overline{n|}}\cdot{}_np_x$

    and

    $\overline{a}_{\overline{t|}} = E\left[ \int_0^t\exp(-J_0^u)du \right] = \int_0^tE\left[ \exp(-J_0^u) \right]du.$

    So, we obtain the expression of $\overline{a}_{x:\overline{n|}}$ though Fubini's theorem as follows,

    $ \overline{a}_{x:\overline{n|}} = \int_0^{+\infty}\exp\left(\left(-\delta_0+t^2\sigma^2/6+\lambda(\beta_t-1)\right)t\right){}_tp_xdt. $ (13)

    In this section, we analyse the APVs of life insurances by taking two whole life insurances for example which are the whole life insurance paying one unit at the end of the year of death and the one paying one unit at the moment of death for some insured $(x)$. Following standard symbols in Bowers et al. (1997), $A_x$ denotes the actuarial present value of the whole life insurance payable at the end of the year of death and $\overline{A}_x$ denotes the one of payable at the moment of death.

    Firstly, we discuss the expression of $A_x$.

    $ Ax=E[exp(K(x)+10δtdt)]=+k=0E(k+10δtdt)P(K(x)=k)=+k=0exp((δ0+(k+1)2σ2/6+λ(βk+11))(k+1))kpxpx+k.
    $

    Secondly, we show the expression of $\overline{A}_x$ under our stochastic interest model.

    $ ¯Ax=E[exp(T(x)0δtdt)]=+0E(u0δtdt)dFT(x)(u)=+uexp((δ0+u2σ2/6+λ(βu1))u)fT(x)(u)du.
    $

    In this section, under different parameter and distribution settings, we calculate the APVs of the $20$-year temporary discrete life annuity-due under the one-point distribution and the two-point distribution assumption and the APVs of the $20$-year temporary continuous life annuity for the annuitant $(30)$ under the uniform distribution of death assumption (refer to Section 3.7 in Bowers et al. (1997)). Note that the numerical analysis on life insurances will not be given because of the similarity. The mortality rate is from China Life Insurance Mortality Table (2010-2013) (CL5, Pension life table for male). The results are shown in Tables 46. Comparing Tables 46 with Tables 13, we find that the APVs of life annuity change about parameters following the same law of the values of expected discounted functions in Section 3.3. This is an inevitable conclusion from the relation between the APVs of life annuities and the values of expected discounted functions.

    Table 4.  APVs of discrete life annuity when $F(z)$ is an one-point distribution.
    $\alpha$ actuarial present value
    $p=0.5$ $p=0.5$ $p=0.6$ $p=0.6$
    $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$
    0.0030 14.4406 15.6128 13.6018 14.6124
    0.0028 14.4325 15.6028 13.6474 14.6663
    0.0026 14.4249 15.5935 13.6937 14.7212
    0.0024 14.4179 15.5848 13.7409 14.7772
    0.0022 14.4114 15.5769 13.7889 14.8341
    0.0020 14.4056 15.5697 13.8378 14.8921

     | Show Table
    DownLoad: CSV
    Table 5.  APVs of discrete life annuity when $F(z)$ is a two-point distribution.
    $\alpha_1$ $\alpha_2$ $q$ actuarial present values
    $p=0.5$ $p=0.5$ $p=0.6$ $p=0.6$
    $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.01$
    0.001 0.003 0.40 14.4182 15.5852 13.7949 14.8415
    0.001 0.003 0.50 14.4126 15.5783 13.8441 14.8999
    0.001 0.003 0.60 14.4070 15.5714 13.8937 14.9587
    0.001 0.004 0.40 14.4477 15.6215 13.6606 14.6825
    0.001 0.004 0.50 14.4371 15.6085 13.7311 14.7661
    0.001 0.004 0.60 14.4266 15.5955 13.8025 14.8507
    0.002 0.003 0.40 14.4265 15.5955 13.6952 14.7231
    0.002 0.003 0.50 14.4230 15.5912 13.7188 14.7510
    0.002 0.003 0.60 14.4196 15.5869 13.7424 14.7790
    0.002 0.004 0.40 14.4562 15.6319 13.5628 14.5666
    0.002 0.004 0.50 14.4477 15.6215 13.6079 14.6199
    0.002 0.004 0.60 14.4392 15.6111 13.6532 14.6735

     | Show Table
    DownLoad: CSV
    Table 6.  APVs of continuous life annuity when $F(z)$ is an uniform distribution.
    $\theta$ actuarial present values
    $p=0.5$ $p=0.5$ $p=0.6$ $p=0.6$
    $\sigma=0.01$ $\sigma=0.02$ $\sigma=0.01$ $\sigma=0.02$
    0.0040 14.1057 15.3728 13.5084 14.6499
    0.0035 14.0963 15.3610 13.5716 14.7259
    0.0030 14.0881 15.3508 13.6365 14.8040
    0.0025 14.0812 15.3422 13.7032 14.8844
    0.0020 14.0757 15.3351 13.7718 14.9671

     | Show Table
    DownLoad: CSV

    In this paper, we introduce a new stochastic interest model in which the force of interest is expressed by a compound Poisson process and a Brownian motion. The advantage of this model is that the random jumping behavior and the continuous tiny random fluctuations are described simultaneously and the adjustment ranges of the force of interest in the random jump part of the proposed model are governed by a random variable sequence, which generalizes the modeling methods in Parker(1994a, 1994b, 1994c) and Li et al. (2017). In addition, we derive the expected discounted functions of the proposed model in general circumstances and further discuss the cases under the one point distribution, the two-point distribution and the uniform distribution assumption on random jumping amplitudes $Z_i$ respectively. We also use the proposed model to study two types of common life annuities. Our numerical analysis shows that both the values of expected discounted functions and the APVs of life annuities are influenced distinctly by the change of the interest model parameters under different distribution assumptions of $Z_i$. Especially when the up-jumping probability $p$ is sufficiently large, the influence of parameters in discrete part of interest model is totally opposite to that when the up-jumping probability $p$ is sufficiently small.

    The work was partially supported by NSFC (Grant No. 71671104 and No. 11571198), the key project of NSSFC (Grant No. 16AZD019), the Ministry of education of Humanities and Social Science project (Grant No. 16YJA910003), Project of Shandong Province Higher Educational Science and Technology Program (Grant No. J15LI01 and No. J17KA162), Special Funds of Taishan Scholars Project of Shandong Province and Incubation Group Project of Financial Statistics and Risk Management of SDUFE.

    All authors declare no conflict of interest.

    [1] Association AP (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). Am Psychiatr Assoc 57: 1546–1548.
    [2] Alonso J, Lepine JP (2007) Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry 68: 3–9. doi: 10.4088/JCP.0207e03
    [3] Bourdon KH, Rae DS, Locke BZ, et al. (1991) Estimating the prevalence of mental disorders in US adults from the Epidemiologic Catchment Area Survey. Public H ealth Rep 107: 663–668.
    [4] Kessler RC, Petukhova M, Sampson NA, et al. (2012) Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J M ethods P sychiatr Res 21: 169–184. doi: 10.1002/mpr.1359
    [5] Bandelow B, Michaelis S (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues C lin Neurosci 17: 327.
    [6] Wittchen HU, Jacobi F (2005) Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. Eur N europsychopharmacol 15: 357–376. doi: 10.1016/j.euroneuro.2005.04.012
    [7] Carta MG, Moro MF, Aguglia E, et al. (2015) The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy. Int J So c Psychiatry 61: 693–699. doi: 10.1177/0020764015573848
    [8] Pitts FN, Mcclure JN (1967) Lactate metabolism in anxiety neurosis. New Eng l J Med 277: 1329–1336. doi: 10.1056/NEJM196712212772502
    [9] Krystal JH, Deutsch DN, Charney DS (1996) The biological basis of panic disorder. J Clin Psychiatry 57: 23–31.
    [10] Uchida R, Del-Ben C, Santos A, et al. (2003) Decreased left temporal lobe volume of panic patients measured by magnetic resonance imaging. Braz J Med Biol Res 36: 925–929. doi: 10.1590/S0100-879X2003000700014
    [11] Massana G, Gasto C, Junque C, et al. (2002) Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with 1 H magnetic resonance spectroscopy. Neuroimage 16: 836–842. doi: 10.1006/nimg.2002.1083
    [12] Bremner JD, Innis RB, White T, et al. (2000) SPECT [I-123] iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 47: 96–106. doi: 10.1016/S0006-3223(99)00188-2
    [13] Sibille E, Pavlides C, Benke D, et al. (2000) Genetic inactivation of the serotonin1A receptor in mice results in downregulation of major GABAA receptor α subunits, reduction of GABAA receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 20: 2758–2765. doi: 10.1523/JNEUROSCI.20-08-02758.2000
    [14] Reiss S (1980) Pavlovian conditioning and human fear: An expectancy model. Behav Ther 11: 380–396. doi: 10.1016/S0005-7894(80)80054-2
    [15] Watt MC, Stewart SH (2000) Anxiety sensitivity mediates the relationships between childhood learning experiences and elevated hypochondriacal concerns in young adulthood. J P sychosom Res 49: 107–118.
    [16] Schmidt NB, Lerew DR, Joiner TE (2000) Prospective evaluation of the etiology of anxiety sensitivity: Test of a scar model. Behav Res Ther 38: 1083–1095. doi: 10.1016/S0005-7967(99)00138-2
    [17] Critchley HD, Wiens S, Rotshtein P, et al. (2004) Neural systems supporting interoceptive awareness. Nat Neurosci 7: 189–195. doi: 10.1038/nn1176
    [18] Regier DA, Narrow WE, Rae DS (1990) The epidemiology of anxiety disorders: The epidemiologic catchment area (ECA) experience. J Psychiatr Res 24: 3–14.
    [19] Alonso J, Angermeyer MC, Bernert S, et al. (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta P sychiatr S cand 109: 21–27.
    [20] Bandelow B, Domschke K (2015) Panic disorder, In: Stein DJ, Vythilingum B, Anxiety Disorder Gender, 2 Eds., Switzerland: Springer Int Publishing, 31–48.
    [21] Weissman MM (1993) Family genetic studies of panic disorder. J Psychiatr Res 27: 69–78.
    [22] Crowe RR, Noyes R, Pauls DL, et al. (1983) A family study of panic disorder. Arch Gen Psychiatry 40: 1065–1069. doi: 10.1001/archpsyc.1983.01790090027004
    [23] Smoller JW, Gardner-Schuster E, Covino J (2010) The genetic basis of panic and phobic anxiety disorders. Am J Med Genet Part C 148: 118–126.
    [24] Goldstein RB, Wickramaratne PJ, Horwath E, et al. (1997) Familial aggregation and phenomenology of Early-Onset (at or before age 20 years): Panic disorder. Arch Gen Psychiatry 54: 271–278. doi: 10.1001/archpsyc.1997.01830150097014
    [25] Kendler KS, Heath A, Martin NG, et al. (1986) Symptoms of anxiety and depression in a volunteer twin population: The etiologic role of genetic and environmental factors. Arch Gen Psychiatry 43: 213–221. doi: 10.1001/archpsyc.1986.01800030023002
    [26] Pauls DL, Bucher KD, Crowe RR, et al. (1980) A genetic study of panic disorder pedigrees. Am J human Genet. 32: 639–644.
    [27] Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233: 702–705.
    [28] Deckert J, Catalano M, Syagailo YV, et al. (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum M ol Genet 8: 621–624.
    [29] Domschke K, Reif A, Weber H, et al. (2011) Neuropeptide S receptor gene--converging evidence for a role in panic disorder. Mol Psychiatry 16: 938. doi: 10.1038/mp.2010.81
    [30] Domschke K, Hohoff C, Jacob C, et al. (2008) Chromosome 4q31–34 panic disorder risk locus: Association of neuropeptide Y Y5 receptor variants. Am J Med Genet Part B 147: 510–516.
    [31] Weber H, Scholz CJ, Domschke K, et al. (2012) Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder. PloS One 7: e37651. doi: 10.1371/journal.pone.0037651
    [32] Maron E, Hettema J, Shlik J (2010) Advances in molecular genetics of panic disorder. Mol Psychiatry 15: 681–701. doi: 10.1038/mp.2009.145
    [33] Keck ME, Kern N, Erhardt A, et al. (2008) Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am Ournal Med Genet Part B 147: 1196–1204.
    [34] Hohoff C, Neumann A, Domschke K, et al. (2009) Association analysis of Rgs7 variants with panic disorder. J N eural T ransm 116: 1523–1528.
    [35] Leygraf A, Hohoff C, Freitag C, et al. (2006) Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm 113: 1921. doi: 10.1007/s00702-006-0484-8
    [36] Koido K, Eller T, Kingo K, et al. (2010) Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J Psychiatr Res 44: 275–277. doi: 10.1016/j.jpsychires.2009.09.001
    [37] Kawai T, Akira S (2007) Signaling to NF-κB by Toll-like receptors. Trends M ol Med 13: 460–469. doi: 10.1016/j.molmed.2007.09.002
    [38] Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60: 350–377. doi: 10.1007/s000180300029
    [39] Boulenger JP, Jerabek I, Jolicoeur FB, et al. (1996) Elevated plasma levels of neuropeptide Y in patients with panic disorder. Am J Psychiatry 153: 114–116. doi: 10.1176/ajp.153.1.114
    [40] Reinscheid RK, Xu YL (2005) Neuropeptide S as a novel arousal promoting peptide transmitter. FEBS J 272: 5689–5693.
    [41] Xu Y-L, Reinscheid RK, Huitron-Resendiz S, et al. (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487–497. doi: 10.1016/j.neuron.2004.08.005
    [42] Okamura N, Hashimoto K, Iyo M, et al. (2007) Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 31: 1444–1448. doi: 10.1016/j.pnpbp.2007.06.026
    [43] Thorgeirsson TE, Oskarsson H, Desnica N, et al. (2003) Anxiety with panic disorder linked to chromosome 9q in Iceland. Am J Hum Genet 72: 1221–1230. doi: 10.1086/375141
    [44] Kong A, Cox NJ (1997) Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61: 1179–1188. doi: 10.1086/301592
    [45] Vanderhaeghen JJ, Signeau J, Gepts W (1975) New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nat 257: 604–605. doi: 10.1038/257604a0
    [46] Huppi K, Siwarski D, Pisegna J, et al. (1995) Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse. Genomics 25: 727–729. doi: 10.1016/0888-7543(95)80018-H
    [47] Kato T, Wang ZW, Zoega T, et al. (1996) Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder. Am J Med Genet Part A 67: 401. doi: 10.1002/(SICI)1096-8628(19960726)67:4<401::AID-AJMG14>3.0.CO;2-N
    [48] Schumacher J, Jamra RA, Becker T, et al. (2005) Investigation of the DAOA/G30 locus in panic disorder. Mol Psychiatry 10: 428–429. doi: 10.1038/sj.mp.4001598
    [49] Maron E, Nikopensius T, Koks S, et al. (2005) Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 15: 17–24. doi: 10.1097/00041444-200503000-00004
    [50] Yoon HK, Yang JC, Lee HJ, et al. (2008) The association between serotonin-related gene polymorphisms and panic disorder. J A nxiety Disord 22: 1529–1534. doi: 10.1016/j.janxdis.2008.03.006
    [51] Middeldorp CM, Hottenga JJ, Slagboom PE, et al. (2008) Linkage on chromosome 14 in a genomewide linkage study of a broad anxiety phenotype. Mol Psychiatry 13: 84. doi: 10.1038/sj.mp.4002061
    [52] Holopainen IE, Metsähonkala E, Kokkonen H, et al. (2001) Decreased binding of [11C] flumazenil in Angelman syndrome patients with GABAA receptor β3 subunit deletions. Ann N eurol 49: 110. doi: 10.1002/1531-8249(200101)49:1<110::AID-ANA17>3.0.CO;2-T
    [53] Strakhova MI, Harvey SC, Cook CM, et al. (2000) A single amino acid residue on the α5 subunit (Ile215) is essential for ligand selectivity at α5β3γ2 γ-aminobutyric acidA receptors. Mol P harmacol 58: 1434–1440.
    [54] Weissman MM, Fyer AJ, Haghighi F, et al. (2000) Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet Part A 96: 24–35. doi: 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E
    [55] MacKinnon DF, Xu J, McMahon FJ, et al. (1998) Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data. Am J Psychiatry 155: 829–831.
    [56] Hamilton SP, Slager SL, Heiman GA, et al. (2002) Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 51: 591–601. doi: 10.1016/S0006-3223(01)01322-1
    [57] Shulman R, Griffiths J, Diewold P (1978) Catechol-O-methyl transferase activity in patients with depressive illness and anxiety states. Br J Psychiatry 132: 133–138. doi: 10.1192/bjp.132.2.133
    [58] Karayiorgou M, Sobin C, Blundell ML, et al. (1999) Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45: 1178. doi: 10.1016/S0006-3223(98)00319-9
    [59] Domschke K, Ohrmann P, Braun M, et al. (2008) Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res Neuroimaging 163: 13–20. doi: 10.1016/j.pscychresns.2007.04.016
    [60] Consortium TPG (2009) Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166: 540–556.
    [61] Otowa T, Kawamura Y, Nishida N, et al. (2012) Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry 2: e186. doi: 10.1038/tp.2012.89
    [62] Gratacos M, Costas J, de Cid R, et al. (2009) Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non‐synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet Part B 150: 808–816.
    [63] Erhardt A, Czibere L, Roeske D, et al. (2010) TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 16: 647.
    [64] Gregersen N, Dahl HA, Buttenschon HN, et al. (2012) A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene. Eur J Hum Genet 20: 84. doi: 10.1038/ejhg.2011.148
    [65] Otowa T, Yoshida E, Sugaya N, et al. (2009) Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 54: 122–126. doi: 10.1038/jhg.2008.17
    [66] Schumacher J, Kristensen AS, Wendland JR, et al. (2001) The genetics of panic disorder. Curr Psychiatry Rep 3: 131–137. doi: 10.1007/s11920-001-0010-5
    [67] Onishchenko N, Karpova N, Sabri F, et al. (2008) Long‐lasting depression‐like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J N eurochem 106: 1378–1387.
    [68] Schroeder M, Hillemacher T, Bleich S, et al. (2012) The epigenetic code in depression: implications for treatment. Clin Pharmacol Ther 91: 310–314. doi: 10.1038/clpt.2011.282
    [69] Dalton VS, Kolshus E, Mcloughlin DM (2014) Epigenetics and depression: Return of the repressed. J A ffective D isord 155: 1–12.
    [70] Hervouet E, Vallette FM, Cartron PF (2009) Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenet 4: 487. doi: 10.4161/epi.4.7.9883
    [71] Angelucci F, Croce N, Spalletta G, et al. (2011) Paroxetine rapidly modulates the expression of brain-derived neurotrophic factor mRNA and protein in a human glioblastoma-astrocytoma cell line. Pharmacol 87: 5–10. doi: 10.1159/000322528
    [72] Qiu T, Zhou L, Zhu W, et al. (2013) Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials. Future O ncol 9: 255–269. doi: 10.2217/fon.12.173
    [73] Shih J, Chen K (1999) MAO-A and-B gene knock-out mice exhibit distinctly different behavior. Neurobiol 7: 235–246.
    [74] Politi E, Balduzzi C, Bussi R, et al. (1999) Artificial neural networks: A study in clinical psychopharmacology. Psychiatry Res 87: 203. doi: 10.1016/S0165-1781(99)00049-9
    [75] Domschke K, Tidow N, Kuithan H, et al. (2012) Monoamine oxidase A gene DNA hypomethylation-a risk factor for panic disorder? Int J Neuropsychopharmacol 15: 1217. doi: 10.1017/S146114571200020X
    [76] Ziegler C, Richter J, Mahr M, et al. (2016) MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy. Transl Psychiatry 6: e773. doi: 10.1038/tp.2016.41
    [77] Domschke K, Zwanzger P (2008) GABAergic and endocannabinoid dysfunction in anxiety-future therapeutic targets? Curr P harm D es 14: 3508–3517.
    [78] Hettema J, An S, Neale M, et al. (2006) Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 11: 752–762. doi: 10.1038/sj.mp.4001845
    [79] Donner J, Sipila T, Ripatti S, et al. (2012) Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility. Am J Med Genet Part B 159: 316–327.
    [80] Bayles R, Baker EK, Jowett JB, et al. (2013) Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One 8: e83223. doi: 10.1371/journal.pone.0083223
    [81] Schartner C, Ziegler C, Schiele MA, et al. (2017) CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder? Eur Neuropsychopharmacol 27: 360–371. doi: 10.1016/j.euroneuro.2017.01.005
  • This article has been cited by:

    1. Debapriya Sarkar, Sushant Prajapati, Kasturi Poddar, Angana Sarkar, Ethanol production by Klebsiella sp. SWET4 using banana peel as feasible substrate, 2020, 2190-6815, 10.1007/s13399-020-00880-1
    2. Cristiano E. Rodrigues Reis, Aravindan Rajendran, Bo Hu, New technologies in value addition to the thin stillage from corn-to-ethanol process, 2017, 16, 1569-1705, 175, 10.1007/s11157-017-9421-6
  • Reader Comments
  • © 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6391) PDF downloads(2182) Cited by(14)

Figures and Tables

Tables(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog